+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Tourette Syndrome Treatment Market

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923068
The global primary biliary cholangitis therapeutics market size was estimated to be USD 2.34 billion in 2023 and is expected to reach USD 4.98 billion by 2034 with a CAGR of 7.12% during the forecast period 2024-2034. Increasing awareness and diagnosis, advancements in research and development, collaborations and partnerships, government initiatives and support, and personalized medicine approaches will drive the market growth. Research points to a possible increase in occurrences of Tourette Syndrome, while the causes of this increase are still being looked at. There is a greater need on the market for efficient treatment options due to the rising number of people with Tourette Syndrome.

Partnerships among pharmaceutical corporations, academic institutions, and healthcare organizations can stimulate the creation of novel therapeutics and improve the treatment environment as a whole. Understanding the molecular and genetic components of Tourette Syndrome better may enable the creation of individualized treatment plans based on the unique characteristics of each patient. For instance, Neurocrine Biosciences submitted a supplementary New Drug Application (sNDA) to the FDA in December 2023, requesting that the label for Ingrezza be amended to cover juvenile tardive dyskinesia associated with Tourette Syndrome.

By product, the antipsychotics segment accounted for the highest revenue-grossing segment in the global Primary Biliary Cholangitis Therapeutics market in 2023 owing to the innovative formulations and expanded treatment options, as well as the proven efficacy of antipsychotics in managing the symptoms associated with Primary Biliary Cholangitis. For instance, in October 2023, Teva Pharmaceutical Industries presented evidence at the CHMP (Committee for Medicinal Products for Human Use) meeting on tetrabenazine's potential for treating tardive dyskinesia in adult Tourette Syndrome patients. Additionally, the non-antipsychotics segment is predicted to grow at the fastest CAGR during the forecast period owing to advancements in targeted therapies, increased research and development efforts, and a growing preference for treatment modalities with fewer side effects.

By distribution channel, the hospitals and clinics segment accounted for the highest revenue-grossing segment in the global Primary Biliary Cholangitis Therapeutics market in 2023 owing to the rising patient admissions, increased diagnostic procedures, and the centralized role of hospitals and clinics in providing comprehensive and specialized care for Primary Biliary Cholangitis. For instance, Pfizer entered into a collaborative agreement with Sozdarai Therapeutics in June 2023 to develop and market innovative gene therapy candidates for neurological illnesses, including Tourette Syndrome. Additionally, the online retailers segment is predicted to grow at the fastest CAGR during the forecast period owing to increased digital adoption, rising consumer preference for online purchasing, and the convenience and accessibility offered by online retailers in the distribution of Primary Biliary Cholangitis Therapeutics.

North American region is anticipated for the highest revenue share during the forecast period owing to the robust healthcare infrastructure, a high prevalence of Primary Biliary Cholangitis cases, and a strong emphasis on research and development activities. For instance, Johnson & Johnson announced the start of a new patient support program called "Living with Tourette Syndrome" in September 2023 to give services and information to individuals and families impacted by the illness. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising prevalence of Primary Biliary Cholangitis, expanding healthcare infrastructure, and a growing focus on healthcare improvements.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Product, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Tourette Syndrome Treatment Market Report 2023 - 2034

Tourette Syndrome Treatment Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)

  • Antipsychotics
  • Non-Antipsychotics
  • Stimulants
  • Alpha-2 adrenergic agonists

Tourette Syndrome Treatment Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospitals and Clinics
  • Pharmacies
  • Online Retailers

Tourette Syndrome Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Tourette Syndrome Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Tourette Syndrome Treatment Market: Product Estimates & Trend Analysis
7.1. Product Segment Opportunity Analysis
7.2. Antipsychotics
7.2.1. Antipsychotics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Non-Antipsychotics
7.3.1. Non-Antipsychotics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Stimulants
7.4.1. Stimulants Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Alpha-2 adrenergic agonists
7.5.1. Alpha-2 adrenergic agonists Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Tourette Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Segment Opportunity Analysis
8.2. Hospitals and Clinics
8.2.1. Hospitals and Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Pharmacies
8.3.1. Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Online Retailers
8.4.1. Online Retailers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Regional Market Analysis
9.1. Regional Market Opportunity Analysis
10. North America Tourette Syndrome Treatment Market
10.1. North America Tourette Syndrome Treatment Market
10.1.1. North America Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.1.2. North America Tourette Syndrome Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
10.1.3. North America Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
10.1.4. North America Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
10.2. U.S. Global Tourette Syndrome Treatment Market
10.2.1. U.S. Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.2.2. U.S. Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
10.2.3. U.S. Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
10.3. Canada Global Tourette Syndrome Treatment Market
10.3.1. Canada Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.3.2. Canada Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
10.3.3. Canada Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11. Europe Global Tourette Syndrome Treatment Market
11.1. Europe Global Tourette Syndrome Treatment Market
11.1.1. Europe Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. Europe Tourette Syndrome Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. Europe Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.1.4. Europe Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. Germany Global Tourette Syndrome Treatment Market
11.2.1. Germany Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. Germany Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.2.3. Germany Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. UK Global Tourette Syndrome Treatment Market
11.3.1. UK Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. UK Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.3.3. UK Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.4. France Global Tourette Syndrome Treatment Market
11.4.1. France Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.4.2. France Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.4.3. France Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.5. Spain Global Tourette Syndrome Treatment Market
11.5.1. Spain Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.5.2. Spain Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.5.3. Spain Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.6. Italy Global Tourette Syndrome Treatment Market
11.6.1. Italy Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.6.2. Italy Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.6.3. Italy Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.7. Rest of Europe Global Tourette Syndrome Treatment Market
11.7.1. Rest of Europe Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.7.2. Rest of Europe Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.7.3. Rest of Europe Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Asia Pacific Global Tourette Syndrome Treatment Market
12.1. Asia Pacific Global Tourette Syndrome Treatment Market
12.1.1. Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.1.4. Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Japan Global Tourette Syndrome Treatment Market
12.2.1. Japan Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Japan Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.2.3. Japan Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. China Global Tourette Syndrome Treatment Market
12.3.1. China Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. China Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.3.3. China Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. India Global Tourette Syndrome Treatment Market
12.4.1. India Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. India Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.4.3. India Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. South Korea Global Tourette Syndrome Treatment Market
12.5.1. South Korea Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. South Korea Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.5.3. South Korea Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Australia Global Tourette Syndrome Treatment Market
12.6.1. Australia Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Australia Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.6.3. Australia Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Asia Pacific Global Tourette Syndrome Treatment Market
12.7.1. Rest of Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Asia Pacific Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Latin America Global Tourette Syndrome Treatment Market
13.1. Latin America Global Tourette Syndrome Treatment Market
13.1.1. Latin America Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Latin America Tourette Syndrome Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Latin America Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.1.4. Latin America Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Brazil Global Tourette Syndrome Treatment Market
13.2.1. Brazil Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Brazil Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.2.3. Brazil Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. Mexico Global Tourette Syndrome Treatment Market
13.3.1. Mexico Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Mexico Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.3.3. Mexico Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. Argentina Global Tourette Syndrome Treatment Market
13.4.1. Argentina Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. Argentina Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.4.3. Argentina Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. Rest of Latin America Global Tourette Syndrome Treatment Market
13.5.1. Rest of Latin America Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Rest of Latin America Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.5.3. Rest of Latin America Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. MEA Global Tourette Syndrome Treatment Market
14.1. MEA Global Tourette Syndrome Treatment Market
14.1.1. MEA Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. MEA Tourette Syndrome Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. MEA Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.1.4. MEA Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. GCC Global Tourette Syndrome Treatment Market
14.2.1. GCC Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. GCC Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.2.3. GCC Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. South Africa Global Tourette Syndrome Treatment Market
14.3.1. South Africa Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. South Africa Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.3.3. South Africa Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Rest of MEA Global Tourette Syndrome Treatment Market
14.4.1. Rest of MEA Tourette Syndrome Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Rest of MEA Tourette Syndrome Treatment Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.4.3. Rest of MEA Tourette Syndrome Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. Competitor Analysis
15.1. Company Market Share Analysis, 2023
15.2. Major Recent Developments
16. Company Profiles
16.1. Neurocrine Biosciences, Inc.
16.2. Teva Pharmaceutical Industries Ltd.
16.3. Pfizer Inc.
16.4. Johnson & Johnson
16.5. Eli Lilly and Company
16.6. Abide Therapeutics
16.7. Takeda Pharmaceutical Company Limited
16.8. Psyadon Pharmaceuticals
17. Conclusion18. Recommendations

Companies Mentioned

  • Neurocrine Biosciences Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Johnson & Johnson
  • Eli Lilly and Company
  • Abide Therapeutics
  • Takeda Pharmaceutical Company Limited
  • Psyadon Pharmaceuticals.

Table Information